Hadassah

Saudi Arabian Media Puts Positive Spotlight on Hadassah Medical Center’s Bone Marrow Registry Outreach to Arabs

Monday, Sep 12 2011

The Saudi Arabian newspaper, Al-Watan (The Homeland) recently published an article by one of its columnists about Israel's superiority in science and technology and showcased the Hadassah University Medical Center's Bone Marrow Registry outreach to Arabs.

The only registry in the world for Arab bone marrow donors, the article said, exists at the Hadassah Medical Center in Jerusalem. The article goes on to report that this is remarkable because there are only 1.2 million Arabs in Israel, compared to more than 400 million in the entire world. The columnist also relates that Dr. Amal Bishara, an Arab Ph.D at Hadassah, has visited more than 60 Arab villages in Israel since the registry was established in 2008. Dr. Bishara is the Director of Hadassah's Arab Bone Marrow Registry Outreach Project.

To date, Hadassah's registry for Arabs has collected almost 10,000 samples. More than 100 requests from all over the world have been received to attempt a bone marrow match--and Hadassah was able to match 40 of them! The 10th transplantation was recently performed out of this special registry.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Hadassah Removes Tumor;
Gazan Boy Walks for First Time

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More